Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2023-01-21 Capital/Financing Update
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement from the Board of Directors of Lyka Labs Limited regarding the outcome of a Board Meeting held on 21st January 2023. It primarily discusses the approval of a preferential issue of equity shares and convertible warrants to the Promoter Group, including specifics on the number of shares, pricing, and terms. It also announces the convening of an Extraordinary General Meeting (EOGM) to seek shareholder approval for this issuance. The document includes regulatory references to SEBI Listing Obligations and Disclosure Requirements, 2015, and provides detailed disclosure information as per Regulation 30. This is a clear update on capital raising activities and changes in the company's capital structure, not a full financial report or earnings release. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2023-01-21 English
In Compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015; this is to inform you that the Board of Directors at its Meeting held today ....
Regulatory Filings
2023-01-21 English
LYKA LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/01/2023 ,inter alia, to consider and approve A meeting of the Board of Directors ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (113 characters) and contains only a digital signature with a date, without any substantive content, financial data, or report information. It does not contain any report, announcement, or detailed information. Given the lack of content, this is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-18 English
Board Meeting — Fund Raising/Other business matters
Regulatory Filings Classification · 95% confidence The document text is extremely short (113 characters) and contains only a digital signature line with a date, without any substantive content, financial data, or report details. It does not contain any report, announcement, or detailed information. Given the lack of content and the presence of a signature, this is likely a regulatory filing or attestation document without substantive report data. According to the Certification Rule, such documents are classified as Regulatory Filings (RNS).
2023-01-18 English
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015; we wish to inform you that the Company has received an intimation from ....
Regulatory Filings Classification · 100% confidence The document text is extremely short (115 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed filing. This matches the criteria for a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-16 English
Loss of Share Certificates
Regulatory Filings Classification · 100% confidence The document text is extremely short (115 characters) and contains only a digital signature with a date. There is no substantive content, financial data, or report information. It does not contain any report, announcement, or detailed filing. This matches the criteria for a Regulatory Filing (RNS) as a fallback category for miscellaneous filings that do not fit other categories.
2023-01-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.